Aspirin for the primary prevention of cardiovascular events [6]

Annals of Internal Medicine

Volumn 137, Issue 7, 2002, Pages 622-623

  McLaughlin, George E ^a  

^a Rheumatology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CORONARY ARTERY THROMBOSIS; HUMAN; LETTER; MEDICAL PRACTICE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL;

EID: 0036788769     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-7-200210010-00024     Document Type: Letter

References (6)

1. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med. 2002;136:157-60. [PMID: 11790071]
2. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:161-72, [PMID: 11790072]
3. Dalen JE. An apple a day or an aspirin a day? Arch Intern Med. 1991;151:1066-9. [PMID: 2043008]
4. Craven LL. Acetylsalicylic acid: possible preventive of coronary thrombosis. Annals of Western Medicine and Surgery. 1950;4:95-9.
5. Craven LL. Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Mississippi Valley Medical Journal. 1953;75:38-44.
6. Craven LL. Prevention of coronary thrombosis and cerebral thrombosis. Mississippi Valley Medical Journal. 1956;78:213-5.